Australia | Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines | | https://www.legislation.gov.au/Details/F2023C00458 |
Australia | Therapeutic Goods Order No. 92 – Standard for labels of non-prescription medicines | | https://www.legislation.gov.au/Details/F2023C00456 |
Australia | Therapeutic Goods Order No. 95 – Child‑resistant packaging requirements for medicines 2017 | | https://www.legislation.gov.au/Details/F2017L01577 |
Australia | Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021 | | https://www.legislation.gov.au/Details/F2021L00595 |
Australia | Therapeutic Goods (Medicines—Standard for Serialisation and Data Matrix Codes) (TGO 106) Order 2021 | | https://www.legislation.gov.au/Details/F2021L00333 |
Australia | Therapeutic Goods (Medicines Advisory Statements) Specification 2021 | | https://www.legislation.gov.au/Details/F2021L01888 |
Australia | Requirements for OTC new medicines N2 applications (using OTC medicine monographs) | | https://www.tga.gov.au/requirements-otc-new-medicines-n2-applications-using-otc-medicine-monographs |
Australia | ARGOM Appendix 2: Guidelines on quality aspects of OTC applications 8. Finished product container | | https://www.tga.gov.au/resources/resource/guidance/argom-appendix-2-guidelines-quality-aspects-otc-applications/8-finished-product-container |
Australia | What’s on my medicine label? | | https://www.tga.gov.au/products/medicines/find-information-about-medicine/whats-my-medicine-label |
Australia | Inhalation and nasal spray registered medicines | | https://www.tga.gov.au/resources/resource/guidance/inhalation-and-nasal-spray-registered-medicines |
Australia | Code of practice for tamper-evident packaging of therapeutic goods | | https://www.tga.gov.au/resources/resource/guidance/code-practice-tamper-evident-packaging-therapeutic-goods |
Australia | Child-resistant packaging requirements for medicines – Guidance on TGO 95 | | https://www.tga.gov.au/resources/resource/guidance/child-resistant-packaging-requirements-medicines-guidance-tgo-95 |
Australia | Biologicals packaged or combined with another therapeutic good | | https://www.tga.gov.au/resources/resource/guidance/biologicals-packaged-or-combined-another-therapeutic-good |
Australia | International scientific guideline: Guideline on plastic immediate packaging materials | | https://www.tga.gov.au/resources/resource/international-scientific-guidelines/international-scientific-guideline-guideline-plastic-immediate-packaging-materials |
Australia | International scientific guideline: ICH topic Q 1 F – Note for guidance on stability data package for registration in climatic zones III and IV | | https://www.tga.gov.au/resources/resource/international-scientific-guidelines/international-scientific-guideline-ich-topic-q-1-f-note-guidance-stability-data-package-registration-climatic-zones-iii-and-iv |
Australia | Supplier assessment, approval and qualification for listed and complementary medicines | | https://www.tga.gov.au/resources/resource/guidance/supplier-assessment-approval-and-qualification-listed-and-complementary-medicines |
Australia | Standard for serialisation and data matrix codes on medicines | | https://www.tga.gov.au/resources/resource/guidance/standard-serialisation-and-data-matrix-codes-medicines |
Australia | Nicotine vaping products and vaping devices | | https://www.tga.gov.au/resources/resource/guidance/nicotine-vaping-products-and-vaping-devices |
Australia | Sampling and testing for listed and complementary medicines | | https://www.tga.gov.au/resources/resource/guidance/sampling-and-testing-listed-and-complementary-medicines |
Australia | National guideline for retail storage of Schedule 6 and Schedule 7 poisons | | https://www.tga.gov.au/resources/resource/guidance/national-guideline-retail-storage-schedule-6-and-schedule-7-poisons |
Australia | Medical device labelling obligations | | https://www.tga.gov.au/resources/resource/guidance/medical-device-labelling-obligations |
Australia | Tips on creating prescription medicine labels compliant with TGO 91 | | https://www.tga.gov.au/resources/resource/guidance/tips-creating-prescription-medicine-labels-compliant-tgo-91 |
Australia | Warnings on labels of medicines containing neuromuscular blocking agents | | https://www.tga.gov.au/resources/resource/guidance/warnings-labels-medicines-containing-neuromuscular-blocking-agents |
Australia | ARGOM Appendix 3: Guidelines on presentation aspects of OTC applications | | https://www.tga.gov.au/resources/resource/guidance/argom-appendix-3-guidelines-presentation-aspects-otc-applications |
Australia | Guidance on the regulation of menstrual cups in Australia | | https://www.tga.gov.au/resources/resource/guidance/guidance-regulation-menstrual-cups-australia |
Australia | Variations to prescription medicines – excluding variations requiring evaluation of clinical or bioequivalence data, Appendix 2: Variation types – biological medicines | | https://www.tga.gov.au/resources/resource/guidance/variations-prescription-medicines-excluding-variations-requiring-evaluation-clinical-or-bioequivalence-data-appendix-2-variation-types-biological-medicines |
Australia | Ongoing stability testing for listed and complementary medicines | | https://www.tga.gov.au/resources/resource/guidance/ongoing-stability-testing-listed-and-complementary-medicines |
Australia | Releasing medicines manufactured at multiple sites | | https://www.tga.gov.au/resources/resource/guidance/releasing-medicines-manufactured-multiple-sites |
Australia | Guidance on the regulation of tampons in Australia | | https://www.tga.gov.au/resources/resource/guidance/guidance-regulation-tampons-australia |
Australia | Medicinal cannabis manufacture | | https://www.tga.gov.au/resources/resource/guidance/medicinal-cannabis-manufacture |
Australia | Electronic Instructions for Use – eIFU | | https://www.tga.gov.au/resources/resource/guidance/electronic-instructions-use-eifu |
Australia | Guidance on the regulation of exempt disinfectants in Australia | | https://www.tga.gov.au/resources/resource/guidance/guidance-regulation-exempt-disinfectants-australia |
Australia | Medicine labels: Guidance on TGO 91 and TGO 92 | | https://www.tga.gov.au/resources/resource/guidance/medicine-labels-guidance-tgo-91-and-tgo-92 |
Australia | The Poisons Standard and medical devices | | https://www.tga.gov.au/resources/resource/guidance/poisons-standard-and-medical-devices |
Australia | Hand sanitisers: Information for manufacturers, suppliers and advertisers | | https://www.tga.gov.au/resources/resource/guidance/hand-sanitisers-information-manufacturers-suppliers-and-advertisers |
Australia | Boxed Warning guidance | | https://www.tga.gov.au/resources/resource/guidance/boxed-warning-guidance |
Australia | ARGB Appendix 11 – Guidance on TGO 107: Standard for Biologicals – Labelling Requirements | | https://www.tga.gov.au/resources/resource/guidance/argb-appendix-11-guidance-tgo-107-standard-biologicals-labelling-requirements |
Australia | Guidelines for using the TGA assessed claim on medicine labels | | https://www.tga.gov.au/resources/resource/guidance/guidelines-using-tga-assessed-claim-medicine-labels |
Australia | What does ‘TGA assessed’ mean on my medicine label? | | https://www.tga.gov.au/resources/resource/guidance/what-does-tga-assessed-mean-my-medicine-label |
Australia | Sampling of starting and packaging material (Annex 8) | | https://www.tga.gov.au/resources/resource/guidance/medicinal-cannabis-manufacture/sampling-starting-and-packaging-material-annex-8 |